Aspira Pathlab & Diagnostics has informed that it enclosed the following disclosure Form - C pursuant to Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 from Shraddha Bhanushali, Directors Immediate Relative of the Company for the acquisition of Equity Shares from the market as on March 18, 2024.
The above information is a part of company’s filings submitted to BSE.